Inovio to report fourth quarter and year end 2024 financial results on march 18, 2025

Plymouth meeting, pa. , march 12, 2025 /prnewswire/ -- inovio (nasdaq:ino), a biotechnology company focused on developing and commercializing dna medicines to help treat and protect people from hpv-associated diseases, cancers, and infectious diseases, today announced that fourth quarter and year-end 2024 financial results will be released after the market close on march 18, 2025.
INO Ratings Summary
INO Quant Ranking